Global Therapeutic Peptide Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Polypeptide molecules are ideal drug molecules due to their high affinity, high selectivity, low toxicity and easy synthesis.
LPI (LP Information)' newest research report, the “Therapeutic Peptide Industry Forecast” looks at past sales and reviews total world Therapeutic Peptide sales in 2022, providing a comprehensive analysis by region and market sector of projected Therapeutic Peptide sales for 2023 through 2029. With Therapeutic Peptide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Peptide industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Peptide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Peptide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Therapeutic Peptide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Peptide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Peptide.
The global Therapeutic Peptide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Therapeutic Peptide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Therapeutic Peptide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Therapeutic Peptide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Therapeutic Peptide players cover AbbVie, AstraZeneca, Ipsen, Eli Lilly, Merck, Novo Nordisk, Novartis, Johnson and Johnson and Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Peptide market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Therapeutic Peptide market?
What factors are driving Therapeutic Peptide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Therapeutic Peptide market opportunities vary by end market size?
How does Therapeutic Peptide break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Polypeptide molecules are ideal drug molecules due to their high affinity, high selectivity, low toxicity and easy synthesis.
LPI (LP Information)' newest research report, the “Therapeutic Peptide Industry Forecast” looks at past sales and reviews total world Therapeutic Peptide sales in 2022, providing a comprehensive analysis by region and market sector of projected Therapeutic Peptide sales for 2023 through 2029. With Therapeutic Peptide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Peptide industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Peptide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Peptide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Therapeutic Peptide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Peptide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Peptide.
The global Therapeutic Peptide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Therapeutic Peptide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Therapeutic Peptide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Therapeutic Peptide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Therapeutic Peptide players cover AbbVie, AstraZeneca, Ipsen, Eli Lilly, Merck, Novo Nordisk, Novartis, Johnson and Johnson and Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Peptide market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Oral
- Injection
- Other
- Cancer
- Metabolic Disorders
- Central Nervous System
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- AstraZeneca
- Ipsen
- Eli Lilly
- Merck
- Novo Nordisk
- Novartis
- Johnson and Johnson
- Sanofi
- Teva
- Takeda
What is the 10-year outlook for the global Therapeutic Peptide market?
What factors are driving Therapeutic Peptide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Therapeutic Peptide market opportunities vary by end market size?
How does Therapeutic Peptide break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Peptide Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Therapeutic Peptide by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Therapeutic Peptide by Country/Region, 2018, 2022 & 2029
2.2 Therapeutic Peptide Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Other
2.3 Therapeutic Peptide Sales by Type
2.3.1 Global Therapeutic Peptide Sales Market Share by Type (2018-2023)
2.3.2 Global Therapeutic Peptide Revenue and Market Share by Type (2018-2023)
2.3.3 Global Therapeutic Peptide Sale Price by Type (2018-2023)
2.4 Therapeutic Peptide Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Therapeutic Peptide Sales by Application
2.5.1 Global Therapeutic Peptide Sale Market Share by Application (2018-2023)
2.5.2 Global Therapeutic Peptide Revenue and Market Share by Application (2018-2023)
2.5.3 Global Therapeutic Peptide Sale Price by Application (2018-2023)
3 GLOBAL THERAPEUTIC PEPTIDE BY COMPANY
3.1 Global Therapeutic Peptide Breakdown Data by Company
3.1.1 Global Therapeutic Peptide Annual Sales by Company (2018-2023)
3.1.2 Global Therapeutic Peptide Sales Market Share by Company (2018-2023)
3.2 Global Therapeutic Peptide Annual Revenue by Company (2018-2023)
3.2.1 Global Therapeutic Peptide Revenue by Company (2018-2023)
3.2.2 Global Therapeutic Peptide Revenue Market Share by Company (2018-2023)
3.3 Global Therapeutic Peptide Sale Price by Company
3.4 Key Manufacturers Therapeutic Peptide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Peptide Product Location Distribution
3.4.2 Players Therapeutic Peptide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR THERAPEUTIC PEPTIDE BY GEOGRAPHIC REGION
4.1 World Historic Therapeutic Peptide Market Size by Geographic Region (2018-2023)
4.1.1 Global Therapeutic Peptide Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Therapeutic Peptide Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Therapeutic Peptide Market Size by Country/Region (2018-2023)
4.2.1 Global Therapeutic Peptide Annual Sales by Country/Region (2018-2023)
4.2.2 Global Therapeutic Peptide Annual Revenue by Country/Region (2018-2023)
4.3 Americas Therapeutic Peptide Sales Growth
4.4 APAC Therapeutic Peptide Sales Growth
4.5 Europe Therapeutic Peptide Sales Growth
4.6 Middle East & Africa Therapeutic Peptide Sales Growth
5 AMERICAS
5.1 Americas Therapeutic Peptide Sales by Country
5.1.1 Americas Therapeutic Peptide Sales by Country (2018-2023)
5.1.2 Americas Therapeutic Peptide Revenue by Country (2018-2023)
5.2 Americas Therapeutic Peptide Sales by Type
5.3 Americas Therapeutic Peptide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Peptide Sales by Region
6.1.1 APAC Therapeutic Peptide Sales by Region (2018-2023)
6.1.2 APAC Therapeutic Peptide Revenue by Region (2018-2023)
6.2 APAC Therapeutic Peptide Sales by Type
6.3 APAC Therapeutic Peptide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Therapeutic Peptide by Country
7.1.1 Europe Therapeutic Peptide Sales by Country (2018-2023)
7.1.2 Europe Therapeutic Peptide Revenue by Country (2018-2023)
7.2 Europe Therapeutic Peptide Sales by Type
7.3 Europe Therapeutic Peptide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Peptide by Country
8.1.1 Middle East & Africa Therapeutic Peptide Sales by Country (2018-2023)
8.1.2 Middle East & Africa Therapeutic Peptide Revenue by Country (2018-2023)
8.2 Middle East & Africa Therapeutic Peptide Sales by Type
8.3 Middle East & Africa Therapeutic Peptide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Therapeutic Peptide
10.3 Manufacturing Process Analysis of Therapeutic Peptide
10.4 Industry Chain Structure of Therapeutic Peptide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Therapeutic Peptide Distributors
11.3 Therapeutic Peptide Customer
12 WORLD FORECAST REVIEW FOR THERAPEUTIC PEPTIDE BY GEOGRAPHIC REGION
12.1 Global Therapeutic Peptide Market Size Forecast by Region
12.1.1 Global Therapeutic Peptide Forecast by Region (2024-2029)
12.1.2 Global Therapeutic Peptide Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Therapeutic Peptide Forecast by Type
12.7 Global Therapeutic Peptide Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Therapeutic Peptide Product Portfolios and Specifications
13.1.3 AbbVie Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Therapeutic Peptide Product Portfolios and Specifications
13.2.3 AstraZeneca Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Ipsen
13.3.1 Ipsen Company Information
13.3.2 Ipsen Therapeutic Peptide Product Portfolios and Specifications
13.3.3 Ipsen Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Ipsen Main Business Overview
13.3.5 Ipsen Latest Developments
13.4 Eli Lilly
13.4.1 Eli Lilly Company Information
13.4.2 Eli Lilly Therapeutic Peptide Product Portfolios and Specifications
13.4.3 Eli Lilly Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Eli Lilly Main Business Overview
13.4.5 Eli Lilly Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Therapeutic Peptide Product Portfolios and Specifications
13.5.3 Merck Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Novo Nordisk
13.6.1 Novo Nordisk Company Information
13.6.2 Novo Nordisk Therapeutic Peptide Product Portfolios and Specifications
13.6.3 Novo Nordisk Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novo Nordisk Main Business Overview
13.6.5 Novo Nordisk Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Therapeutic Peptide Product Portfolios and Specifications
13.7.3 Novartis Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Johnson and Johnson
13.8.1 Johnson and Johnson Company Information
13.8.2 Johnson and Johnson Therapeutic Peptide Product Portfolios and Specifications
13.8.3 Johnson and Johnson Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Johnson and Johnson Main Business Overview
13.8.5 Johnson and Johnson Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Therapeutic Peptide Product Portfolios and Specifications
13.9.3 Sanofi Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Teva
13.10.1 Teva Company Information
13.10.2 Teva Therapeutic Peptide Product Portfolios and Specifications
13.10.3 Teva Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teva Main Business Overview
13.10.5 Teva Latest Developments
13.11 Takeda
13.11.1 Takeda Company Information
13.11.2 Takeda Therapeutic Peptide Product Portfolios and Specifications
13.11.3 Takeda Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Takeda Main Business Overview
13.11.5 Takeda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Peptide Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Therapeutic Peptide by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Therapeutic Peptide by Country/Region, 2018, 2022 & 2029
2.2 Therapeutic Peptide Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Other
2.3 Therapeutic Peptide Sales by Type
2.3.1 Global Therapeutic Peptide Sales Market Share by Type (2018-2023)
2.3.2 Global Therapeutic Peptide Revenue and Market Share by Type (2018-2023)
2.3.3 Global Therapeutic Peptide Sale Price by Type (2018-2023)
2.4 Therapeutic Peptide Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Therapeutic Peptide Sales by Application
2.5.1 Global Therapeutic Peptide Sale Market Share by Application (2018-2023)
2.5.2 Global Therapeutic Peptide Revenue and Market Share by Application (2018-2023)
2.5.3 Global Therapeutic Peptide Sale Price by Application (2018-2023)
3 GLOBAL THERAPEUTIC PEPTIDE BY COMPANY
3.1 Global Therapeutic Peptide Breakdown Data by Company
3.1.1 Global Therapeutic Peptide Annual Sales by Company (2018-2023)
3.1.2 Global Therapeutic Peptide Sales Market Share by Company (2018-2023)
3.2 Global Therapeutic Peptide Annual Revenue by Company (2018-2023)
3.2.1 Global Therapeutic Peptide Revenue by Company (2018-2023)
3.2.2 Global Therapeutic Peptide Revenue Market Share by Company (2018-2023)
3.3 Global Therapeutic Peptide Sale Price by Company
3.4 Key Manufacturers Therapeutic Peptide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Peptide Product Location Distribution
3.4.2 Players Therapeutic Peptide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR THERAPEUTIC PEPTIDE BY GEOGRAPHIC REGION
4.1 World Historic Therapeutic Peptide Market Size by Geographic Region (2018-2023)
4.1.1 Global Therapeutic Peptide Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Therapeutic Peptide Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Therapeutic Peptide Market Size by Country/Region (2018-2023)
4.2.1 Global Therapeutic Peptide Annual Sales by Country/Region (2018-2023)
4.2.2 Global Therapeutic Peptide Annual Revenue by Country/Region (2018-2023)
4.3 Americas Therapeutic Peptide Sales Growth
4.4 APAC Therapeutic Peptide Sales Growth
4.5 Europe Therapeutic Peptide Sales Growth
4.6 Middle East & Africa Therapeutic Peptide Sales Growth
5 AMERICAS
5.1 Americas Therapeutic Peptide Sales by Country
5.1.1 Americas Therapeutic Peptide Sales by Country (2018-2023)
5.1.2 Americas Therapeutic Peptide Revenue by Country (2018-2023)
5.2 Americas Therapeutic Peptide Sales by Type
5.3 Americas Therapeutic Peptide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Peptide Sales by Region
6.1.1 APAC Therapeutic Peptide Sales by Region (2018-2023)
6.1.2 APAC Therapeutic Peptide Revenue by Region (2018-2023)
6.2 APAC Therapeutic Peptide Sales by Type
6.3 APAC Therapeutic Peptide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Therapeutic Peptide by Country
7.1.1 Europe Therapeutic Peptide Sales by Country (2018-2023)
7.1.2 Europe Therapeutic Peptide Revenue by Country (2018-2023)
7.2 Europe Therapeutic Peptide Sales by Type
7.3 Europe Therapeutic Peptide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Peptide by Country
8.1.1 Middle East & Africa Therapeutic Peptide Sales by Country (2018-2023)
8.1.2 Middle East & Africa Therapeutic Peptide Revenue by Country (2018-2023)
8.2 Middle East & Africa Therapeutic Peptide Sales by Type
8.3 Middle East & Africa Therapeutic Peptide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Therapeutic Peptide
10.3 Manufacturing Process Analysis of Therapeutic Peptide
10.4 Industry Chain Structure of Therapeutic Peptide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Therapeutic Peptide Distributors
11.3 Therapeutic Peptide Customer
12 WORLD FORECAST REVIEW FOR THERAPEUTIC PEPTIDE BY GEOGRAPHIC REGION
12.1 Global Therapeutic Peptide Market Size Forecast by Region
12.1.1 Global Therapeutic Peptide Forecast by Region (2024-2029)
12.1.2 Global Therapeutic Peptide Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Therapeutic Peptide Forecast by Type
12.7 Global Therapeutic Peptide Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Therapeutic Peptide Product Portfolios and Specifications
13.1.3 AbbVie Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Therapeutic Peptide Product Portfolios and Specifications
13.2.3 AstraZeneca Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Ipsen
13.3.1 Ipsen Company Information
13.3.2 Ipsen Therapeutic Peptide Product Portfolios and Specifications
13.3.3 Ipsen Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Ipsen Main Business Overview
13.3.5 Ipsen Latest Developments
13.4 Eli Lilly
13.4.1 Eli Lilly Company Information
13.4.2 Eli Lilly Therapeutic Peptide Product Portfolios and Specifications
13.4.3 Eli Lilly Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Eli Lilly Main Business Overview
13.4.5 Eli Lilly Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Therapeutic Peptide Product Portfolios and Specifications
13.5.3 Merck Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Novo Nordisk
13.6.1 Novo Nordisk Company Information
13.6.2 Novo Nordisk Therapeutic Peptide Product Portfolios and Specifications
13.6.3 Novo Nordisk Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novo Nordisk Main Business Overview
13.6.5 Novo Nordisk Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Therapeutic Peptide Product Portfolios and Specifications
13.7.3 Novartis Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Johnson and Johnson
13.8.1 Johnson and Johnson Company Information
13.8.2 Johnson and Johnson Therapeutic Peptide Product Portfolios and Specifications
13.8.3 Johnson and Johnson Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Johnson and Johnson Main Business Overview
13.8.5 Johnson and Johnson Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Therapeutic Peptide Product Portfolios and Specifications
13.9.3 Sanofi Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Teva
13.10.1 Teva Company Information
13.10.2 Teva Therapeutic Peptide Product Portfolios and Specifications
13.10.3 Teva Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teva Main Business Overview
13.10.5 Teva Latest Developments
13.11 Takeda
13.11.1 Takeda Company Information
13.11.2 Takeda Therapeutic Peptide Product Portfolios and Specifications
13.11.3 Takeda Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Takeda Main Business Overview
13.11.5 Takeda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Therapeutic Peptide Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Therapeutic Peptide Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Major Players of Other
Table 6. Global Therapeutic Peptide Sales by Type (2018-2023) & (K Units)
Table 7. Global Therapeutic Peptide Sales Market Share by Type (2018-2023)
Table 8. Global Therapeutic Peptide Revenue by Type (2018-2023) & ($ million)
Table 9. Global Therapeutic Peptide Revenue Market Share by Type (2018-2023)
Table 10. Global Therapeutic Peptide Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Therapeutic Peptide Sales by Application (2018-2023) & (K Units)
Table 12. Global Therapeutic Peptide Sales Market Share by Application (2018-2023)
Table 13. Global Therapeutic Peptide Revenue by Application (2018-2023)
Table 14. Global Therapeutic Peptide Revenue Market Share by Application (2018-2023)
Table 15. Global Therapeutic Peptide Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Therapeutic Peptide Sales by Company (2018-2023) & (K Units)
Table 17. Global Therapeutic Peptide Sales Market Share by Company (2018-2023)
Table 18. Global Therapeutic Peptide Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Therapeutic Peptide Revenue Market Share by Company (2018-2023)
Table 20. Global Therapeutic Peptide Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Therapeutic Peptide Producing Area Distribution and Sales Area
Table 22. Players Therapeutic Peptide Products Offered
Table 23. Therapeutic Peptide Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Therapeutic Peptide Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Therapeutic Peptide Sales Market Share Geographic Region (2018-2023)
Table 28. Global Therapeutic Peptide Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Therapeutic Peptide Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Therapeutic Peptide Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Therapeutic Peptide Sales Market Share by Country/Region (2018-2023)
Table 32. Global Therapeutic Peptide Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Therapeutic Peptide Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Therapeutic Peptide Sales by Country (2018-2023) & (K Units)
Table 35. Americas Therapeutic Peptide Sales Market Share by Country (2018-2023)
Table 36. Americas Therapeutic Peptide Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Therapeutic Peptide Revenue Market Share by Country (2018-2023)
Table 38. Americas Therapeutic Peptide Sales by Type (2018-2023) & (K Units)
Table 39. Americas Therapeutic Peptide Sales by Application (2018-2023) & (K Units)
Table 40. APAC Therapeutic Peptide Sales by Region (2018-2023) & (K Units)
Table 41. APAC Therapeutic Peptide Sales Market Share by Region (2018-2023)
Table 42. APAC Therapeutic Peptide Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Therapeutic Peptide Revenue Market Share by Region (2018-2023)
Table 44. APAC Therapeutic Peptide Sales by Type (2018-2023) & (K Units)
Table 45. APAC Therapeutic Peptide Sales by Application (2018-2023) & (K Units)
Table 46. Europe Therapeutic Peptide Sales by Country (2018-2023) & (K Units)
Table 47. Europe Therapeutic Peptide Sales Market Share by Country (2018-2023)
Table 48. Europe Therapeutic Peptide Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Therapeutic Peptide Revenue Market Share by Country (2018-2023)
Table 50. Europe Therapeutic Peptide Sales by Type (2018-2023) & (K Units)
Table 51. Europe Therapeutic Peptide Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Therapeutic Peptide Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Therapeutic Peptide Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Therapeutic Peptide Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Therapeutic Peptide Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Therapeutic Peptide Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Therapeutic Peptide Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Therapeutic Peptide
Table 59. Key Market Challenges & Risks of Therapeutic Peptide
Table 60. Key Industry Trends of Therapeutic Peptide
Table 61. Therapeutic Peptide Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Therapeutic Peptide Distributors List
Table 64. Therapeutic Peptide Customer List
Table 65. Global Therapeutic Peptide Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Therapeutic Peptide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Therapeutic Peptide Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Therapeutic Peptide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Therapeutic Peptide Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Therapeutic Peptide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Therapeutic Peptide Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Therapeutic Peptide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Therapeutic Peptide Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Therapeutic Peptide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Therapeutic Peptide Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Therapeutic Peptide Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Therapeutic Peptide Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Therapeutic Peptide Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. AbbVie Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 80. AbbVie Therapeutic Peptide Product Portfolios and Specifications
Table 81. AbbVie Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. AbbVie Main Business
Table 83. AbbVie Latest Developments
Table 84. AstraZeneca Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 85. AstraZeneca Therapeutic Peptide Product Portfolios and Specifications
Table 86. AstraZeneca Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. AstraZeneca Main Business
Table 88. AstraZeneca Latest Developments
Table 89. Ipsen Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 90. Ipsen Therapeutic Peptide Product Portfolios and Specifications
Table 91. Ipsen Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Ipsen Main Business
Table 93. Ipsen Latest Developments
Table 94. Eli Lilly Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 95. Eli Lilly Therapeutic Peptide Product Portfolios and Specifications
Table 96. Eli Lilly Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Eli Lilly Main Business
Table 98. Eli Lilly Latest Developments
Table 99. Merck Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck Therapeutic Peptide Product Portfolios and Specifications
Table 101. Merck Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 104. Novo Nordisk Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 105. Novo Nordisk Therapeutic Peptide Product Portfolios and Specifications
Table 106. Novo Nordisk Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Novo Nordisk Main Business
Table 108. Novo Nordisk Latest Developments
Table 109. Novartis Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 110. Novartis Therapeutic Peptide Product Portfolios and Specifications
Table 111. Novartis Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Novartis Main Business
Table 113. Novartis Latest Developments
Table 114. Johnson and Johnson Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 115. Johnson and Johnson Therapeutic Peptide Product Portfolios and Specifications
Table 116. Johnson and Johnson Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Johnson and Johnson Main Business
Table 118. Johnson and Johnson Latest Developments
Table 119. Sanofi Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 120. Sanofi Therapeutic Peptide Product Portfolios and Specifications
Table 121. Sanofi Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Sanofi Main Business
Table 123. Sanofi Latest Developments
Table 124. Teva Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 125. Teva Therapeutic Peptide Product Portfolios and Specifications
Table 126. Teva Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Teva Main Business
Table 128. Teva Latest Developments
Table 129. Takeda Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 130. Takeda Therapeutic Peptide Product Portfolios and Specifications
Table 131. Takeda Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Takeda Main Business
Table 133. Takeda Latest Developments
Table 1. Therapeutic Peptide Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Therapeutic Peptide Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Major Players of Other
Table 6. Global Therapeutic Peptide Sales by Type (2018-2023) & (K Units)
Table 7. Global Therapeutic Peptide Sales Market Share by Type (2018-2023)
Table 8. Global Therapeutic Peptide Revenue by Type (2018-2023) & ($ million)
Table 9. Global Therapeutic Peptide Revenue Market Share by Type (2018-2023)
Table 10. Global Therapeutic Peptide Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Therapeutic Peptide Sales by Application (2018-2023) & (K Units)
Table 12. Global Therapeutic Peptide Sales Market Share by Application (2018-2023)
Table 13. Global Therapeutic Peptide Revenue by Application (2018-2023)
Table 14. Global Therapeutic Peptide Revenue Market Share by Application (2018-2023)
Table 15. Global Therapeutic Peptide Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Therapeutic Peptide Sales by Company (2018-2023) & (K Units)
Table 17. Global Therapeutic Peptide Sales Market Share by Company (2018-2023)
Table 18. Global Therapeutic Peptide Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Therapeutic Peptide Revenue Market Share by Company (2018-2023)
Table 20. Global Therapeutic Peptide Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Therapeutic Peptide Producing Area Distribution and Sales Area
Table 22. Players Therapeutic Peptide Products Offered
Table 23. Therapeutic Peptide Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Therapeutic Peptide Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Therapeutic Peptide Sales Market Share Geographic Region (2018-2023)
Table 28. Global Therapeutic Peptide Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Therapeutic Peptide Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Therapeutic Peptide Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Therapeutic Peptide Sales Market Share by Country/Region (2018-2023)
Table 32. Global Therapeutic Peptide Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Therapeutic Peptide Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Therapeutic Peptide Sales by Country (2018-2023) & (K Units)
Table 35. Americas Therapeutic Peptide Sales Market Share by Country (2018-2023)
Table 36. Americas Therapeutic Peptide Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Therapeutic Peptide Revenue Market Share by Country (2018-2023)
Table 38. Americas Therapeutic Peptide Sales by Type (2018-2023) & (K Units)
Table 39. Americas Therapeutic Peptide Sales by Application (2018-2023) & (K Units)
Table 40. APAC Therapeutic Peptide Sales by Region (2018-2023) & (K Units)
Table 41. APAC Therapeutic Peptide Sales Market Share by Region (2018-2023)
Table 42. APAC Therapeutic Peptide Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Therapeutic Peptide Revenue Market Share by Region (2018-2023)
Table 44. APAC Therapeutic Peptide Sales by Type (2018-2023) & (K Units)
Table 45. APAC Therapeutic Peptide Sales by Application (2018-2023) & (K Units)
Table 46. Europe Therapeutic Peptide Sales by Country (2018-2023) & (K Units)
Table 47. Europe Therapeutic Peptide Sales Market Share by Country (2018-2023)
Table 48. Europe Therapeutic Peptide Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Therapeutic Peptide Revenue Market Share by Country (2018-2023)
Table 50. Europe Therapeutic Peptide Sales by Type (2018-2023) & (K Units)
Table 51. Europe Therapeutic Peptide Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Therapeutic Peptide Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Therapeutic Peptide Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Therapeutic Peptide Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Therapeutic Peptide Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Therapeutic Peptide Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Therapeutic Peptide Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Therapeutic Peptide
Table 59. Key Market Challenges & Risks of Therapeutic Peptide
Table 60. Key Industry Trends of Therapeutic Peptide
Table 61. Therapeutic Peptide Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Therapeutic Peptide Distributors List
Table 64. Therapeutic Peptide Customer List
Table 65. Global Therapeutic Peptide Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Therapeutic Peptide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Therapeutic Peptide Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Therapeutic Peptide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Therapeutic Peptide Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Therapeutic Peptide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Therapeutic Peptide Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Therapeutic Peptide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Therapeutic Peptide Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Therapeutic Peptide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Therapeutic Peptide Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Therapeutic Peptide Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Therapeutic Peptide Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Therapeutic Peptide Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. AbbVie Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 80. AbbVie Therapeutic Peptide Product Portfolios and Specifications
Table 81. AbbVie Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. AbbVie Main Business
Table 83. AbbVie Latest Developments
Table 84. AstraZeneca Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 85. AstraZeneca Therapeutic Peptide Product Portfolios and Specifications
Table 86. AstraZeneca Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. AstraZeneca Main Business
Table 88. AstraZeneca Latest Developments
Table 89. Ipsen Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 90. Ipsen Therapeutic Peptide Product Portfolios and Specifications
Table 91. Ipsen Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Ipsen Main Business
Table 93. Ipsen Latest Developments
Table 94. Eli Lilly Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 95. Eli Lilly Therapeutic Peptide Product Portfolios and Specifications
Table 96. Eli Lilly Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Eli Lilly Main Business
Table 98. Eli Lilly Latest Developments
Table 99. Merck Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck Therapeutic Peptide Product Portfolios and Specifications
Table 101. Merck Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 104. Novo Nordisk Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 105. Novo Nordisk Therapeutic Peptide Product Portfolios and Specifications
Table 106. Novo Nordisk Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Novo Nordisk Main Business
Table 108. Novo Nordisk Latest Developments
Table 109. Novartis Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 110. Novartis Therapeutic Peptide Product Portfolios and Specifications
Table 111. Novartis Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Novartis Main Business
Table 113. Novartis Latest Developments
Table 114. Johnson and Johnson Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 115. Johnson and Johnson Therapeutic Peptide Product Portfolios and Specifications
Table 116. Johnson and Johnson Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Johnson and Johnson Main Business
Table 118. Johnson and Johnson Latest Developments
Table 119. Sanofi Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 120. Sanofi Therapeutic Peptide Product Portfolios and Specifications
Table 121. Sanofi Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Sanofi Main Business
Table 123. Sanofi Latest Developments
Table 124. Teva Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 125. Teva Therapeutic Peptide Product Portfolios and Specifications
Table 126. Teva Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Teva Main Business
Table 128. Teva Latest Developments
Table 129. Takeda Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 130. Takeda Therapeutic Peptide Product Portfolios and Specifications
Table 131. Takeda Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Takeda Main Business
Table 133. Takeda Latest Developments
LIST OF FIGURES
Figure 1. Picture of Therapeutic Peptide
Figure 2. Therapeutic Peptide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Therapeutic Peptide Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Therapeutic Peptide Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Therapeutic Peptide Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injection
Figure 11. Product Picture of Other
Figure 12. Global Therapeutic Peptide Sales Market Share by Type in 2022
Figure 13. Global Therapeutic Peptide Revenue Market Share by Type (2018-2023)
Figure 14. Therapeutic Peptide Consumed in Cancer
Figure 15. Global Therapeutic Peptide Market: Cancer (2018-2023) & (K Units)
Figure 16. Therapeutic Peptide Consumed in Metabolic Disorders
Figure 17. Global Therapeutic Peptide Market: Metabolic Disorders (2018-2023) & (K Units)
Figure 18. Therapeutic Peptide Consumed in Central Nervous System
Figure 19. Global Therapeutic Peptide Market: Central Nervous System (2018-2023) & (K Units)
Figure 20. Therapeutic Peptide Consumed in Other
Figure 21. Global Therapeutic Peptide Market: Other (2018-2023) & (K Units)
Figure 22. Global Therapeutic Peptide Sales Market Share by Application (2022)
Figure 23. Global Therapeutic Peptide Revenue Market Share by Application in 2022
Figure 24. Therapeutic Peptide Sales Market by Company in 2022 (K Units)
Figure 25. Global Therapeutic Peptide Sales Market Share by Company in 2022
Figure 26. Therapeutic Peptide Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Therapeutic Peptide Revenue Market Share by Company in 2022
Figure 28. Global Therapeutic Peptide Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Therapeutic Peptide Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Therapeutic Peptide Sales 2018-2023 (K Units)
Figure 31. Americas Therapeutic Peptide Revenue 2018-2023 ($ Millions)
Figure 32. APAC Therapeutic Peptide Sales 2018-2023 (K Units)
Figure 33. APAC Therapeutic Peptide Revenue 2018-2023 ($ Millions)
Figure 34. Europe Therapeutic Peptide Sales 2018-2023 (K Units)
Figure 35. Europe Therapeutic Peptide Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Therapeutic Peptide Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Therapeutic Peptide Revenue 2018-2023 ($ Millions)
Figure 38. Americas Therapeutic Peptide Sales Market Share by Country in 2022
Figure 39. Americas Therapeutic Peptide Revenue Market Share by Country in 2022
Figure 40. Americas Therapeutic Peptide Sales Market Share by Type (2018-2023)
Figure 41. Americas Therapeutic Peptide Sales Market Share by Application (2018-2023)
Figure 42. United States Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Therapeutic Peptide Sales Market Share by Region in 2022
Figure 47. APAC Therapeutic Peptide Revenue Market Share by Regions in 2022
Figure 48. APAC Therapeutic Peptide Sales Market Share by Type (2018-2023)
Figure 49. APAC Therapeutic Peptide Sales Market Share by Application (2018-2023)
Figure 50. China Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Therapeutic Peptide Sales Market Share by Country in 2022
Figure 58. Europe Therapeutic Peptide Revenue Market Share by Country in 2022
Figure 59. Europe Therapeutic Peptide Sales Market Share by Type (2018-2023)
Figure 60. Europe Therapeutic Peptide Sales Market Share by Application (2018-2023)
Figure 61. Germany Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Therapeutic Peptide Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Therapeutic Peptide Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Therapeutic Peptide Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Therapeutic Peptide Sales Market Share by Application (2018-2023)
Figure 70. Egypt Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Therapeutic Peptide in 2022
Figure 76. Manufacturing Process Analysis of Therapeutic Peptide
Figure 77. Industry Chain Structure of Therapeutic Peptide
Figure 78. Channels of Distribution
Figure 79. Global Therapeutic Peptide Sales Market Forecast by Region (2024-2029)
Figure 80. Global Therapeutic Peptide Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Therapeutic Peptide Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Therapeutic Peptide Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Therapeutic Peptide Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Therapeutic Peptide Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Therapeutic Peptide
Figure 2. Therapeutic Peptide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Therapeutic Peptide Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Therapeutic Peptide Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Therapeutic Peptide Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injection
Figure 11. Product Picture of Other
Figure 12. Global Therapeutic Peptide Sales Market Share by Type in 2022
Figure 13. Global Therapeutic Peptide Revenue Market Share by Type (2018-2023)
Figure 14. Therapeutic Peptide Consumed in Cancer
Figure 15. Global Therapeutic Peptide Market: Cancer (2018-2023) & (K Units)
Figure 16. Therapeutic Peptide Consumed in Metabolic Disorders
Figure 17. Global Therapeutic Peptide Market: Metabolic Disorders (2018-2023) & (K Units)
Figure 18. Therapeutic Peptide Consumed in Central Nervous System
Figure 19. Global Therapeutic Peptide Market: Central Nervous System (2018-2023) & (K Units)
Figure 20. Therapeutic Peptide Consumed in Other
Figure 21. Global Therapeutic Peptide Market: Other (2018-2023) & (K Units)
Figure 22. Global Therapeutic Peptide Sales Market Share by Application (2022)
Figure 23. Global Therapeutic Peptide Revenue Market Share by Application in 2022
Figure 24. Therapeutic Peptide Sales Market by Company in 2022 (K Units)
Figure 25. Global Therapeutic Peptide Sales Market Share by Company in 2022
Figure 26. Therapeutic Peptide Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Therapeutic Peptide Revenue Market Share by Company in 2022
Figure 28. Global Therapeutic Peptide Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Therapeutic Peptide Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Therapeutic Peptide Sales 2018-2023 (K Units)
Figure 31. Americas Therapeutic Peptide Revenue 2018-2023 ($ Millions)
Figure 32. APAC Therapeutic Peptide Sales 2018-2023 (K Units)
Figure 33. APAC Therapeutic Peptide Revenue 2018-2023 ($ Millions)
Figure 34. Europe Therapeutic Peptide Sales 2018-2023 (K Units)
Figure 35. Europe Therapeutic Peptide Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Therapeutic Peptide Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Therapeutic Peptide Revenue 2018-2023 ($ Millions)
Figure 38. Americas Therapeutic Peptide Sales Market Share by Country in 2022
Figure 39. Americas Therapeutic Peptide Revenue Market Share by Country in 2022
Figure 40. Americas Therapeutic Peptide Sales Market Share by Type (2018-2023)
Figure 41. Americas Therapeutic Peptide Sales Market Share by Application (2018-2023)
Figure 42. United States Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Therapeutic Peptide Sales Market Share by Region in 2022
Figure 47. APAC Therapeutic Peptide Revenue Market Share by Regions in 2022
Figure 48. APAC Therapeutic Peptide Sales Market Share by Type (2018-2023)
Figure 49. APAC Therapeutic Peptide Sales Market Share by Application (2018-2023)
Figure 50. China Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Therapeutic Peptide Sales Market Share by Country in 2022
Figure 58. Europe Therapeutic Peptide Revenue Market Share by Country in 2022
Figure 59. Europe Therapeutic Peptide Sales Market Share by Type (2018-2023)
Figure 60. Europe Therapeutic Peptide Sales Market Share by Application (2018-2023)
Figure 61. Germany Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Therapeutic Peptide Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Therapeutic Peptide Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Therapeutic Peptide Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Therapeutic Peptide Sales Market Share by Application (2018-2023)
Figure 70. Egypt Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Therapeutic Peptide Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Therapeutic Peptide in 2022
Figure 76. Manufacturing Process Analysis of Therapeutic Peptide
Figure 77. Industry Chain Structure of Therapeutic Peptide
Figure 78. Channels of Distribution
Figure 79. Global Therapeutic Peptide Sales Market Forecast by Region (2024-2029)
Figure 80. Global Therapeutic Peptide Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Therapeutic Peptide Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Therapeutic Peptide Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Therapeutic Peptide Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Therapeutic Peptide Revenue Market Share Forecast by Application (2024-2029)
